Search
Search Results
##search.searchResults.foundPlural##
-
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3817PDF: 1683HTML: 11632Figures Haase: 207 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4326PDF: 3561HTML: 221 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1404HTML: 475PDF: 834 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
809PDF: 96HTML: 146 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2882PDF: 858HTML: 6533Untitled: 237Untitled: 200Untitled: 212Untitled: 225 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2000PDF: 923HTML: 1770Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 170 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3666PDF: 903HTML: 6722 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3198PDF: 1125HTML: 1781 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3404PDF: 1295HTML: 2230Fi.1 Gritti.Rambaldi: 210 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1778PDF: 1296HTML: 11519Figure1: 179Figure 2: 181 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6898PDF: 3666HTML: 773 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1845PDF: 827HTML: 10240Figures 1,2,3: 189 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4115PDF: 1264HTML: 1963Table 1: 204 -
BETA-GLOBIN GENE MUTATIONS IN TURKISH CHILDREN WITH BETA-THALASSEMIA: RESULTS FROM A SINGLE CENTER STUDY
1677PDF: 699HTML: 1643Beta-globin Gene Mutations in Turkish Children with Beta-Thalassemia: Results from a Single Center Study: 191 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2491PDF: 796HTML: 1738 -
-
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1440PDF: 1242HTML: 487 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2298PDF: 621Suppl. Files: 286HTML: 178 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2426PDF: 966HTML: 396Supplementary table 1: 228Some of the mutation detection samples: 218 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
2063PDF: 1644HTML: 14651Untitled: 215Untitled: 182 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2615PDF: 880HTML: 17572Fig1 Caligaris: 181Fig.2 Caliga: 218 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13292PDF: 987HTML: 7296 -
Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes Clinical & laboratory features of Hb La Desirade trait and compound heterozygous for Hb La Desirade and HbS Hemoglobin.
1652PDF: 478HTML: 257 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2286PDF: 907HTML: 2100 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3336PDF: 1622HTML: 448 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2582PDF: 1171HTML: 145 -
A case of iron deficiency anemia with co-existing Hb Fontainebleau.
1347PDF: 767HTML: 2066Untitled: 306 -
-
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1408PDF: 776HTML: 946







